Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Avantor

Market Cap: US$9.1b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Krka d. d

Market Cap: €7.9b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

RemeGen

Market Cap: HK$71.4b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

Qiagen

Market Cap: US$8.8b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Bruker

Market Cap: US$8.8b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥58.3b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Eisai

Market Cap: JP¥1.3t

Engages in the research, development, manufacture, and sale of pharmaceuticals in Japan.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Alkermes

Market Cap: US$8.2b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$62.1b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Twist Bioscience

Market Cap: US$7.8b

Manufactures and sells synthetic DNA-based products.

Gedeon Richter

Market Cap: Ft2.4t

Researches, develops, manufactures, markets, and sells pharmaceutical products.

Ono Pharmaceutical

Market Cap: JP¥1.1t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Samsung Epis Holdings

Market Cap: ₩9.5t

A biotechnology company, manage the portfolio of biopharmaceutical products.

Caris Life Sciences

Market Cap: US$6.1b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Ligand Pharmaceuticals

Market Cap: US$5.9b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Stevanato Group

Market Cap: US$5.8b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

3SBio

Market Cap: HK$42.3b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Sotera Health

Market Cap: US$5.4b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

SK Biopharmaceuticals

Market Cap: ₩6.7t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Imeik Technology DevelopmentLtd

Market Cap: CN¥29.4b

Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.

Tango Therapeutics

Market Cap: US$4.3b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Yuhan

Market Cap: ₩5.9t

Operates as a pharmaceutical company in South Korea and internationally.

Telix Pharmaceuticals

Market Cap: AU$5.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Aspen Pharmacare Holdings

Market Cap: R63.0b

Operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas.

Livzon Pharmaceutical Group

Market Cap: CN¥23.9b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

Hanmi Pharm

Market Cap: ₩5.0t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

IDEAYA Biosciences

Market Cap: US$3.5b

A precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Veracyte

Market Cap: US$3.3b

Operates as a diagnostics company in the United States and internationally.

InSilico Medicine Cayman TopCo

Market Cap: HK$23.7b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

Chengdu Kanghong Pharmaceutical Group

Market Cap: CN¥20.3b

Engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China.

Tecan Group

Market Cap: CHF 2.4b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Almirall

Market Cap: €2.3b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.8b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

Mesoblast

Market Cap: AU$3.1b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.